Mounjaro is a once-weekly injectable medication approved by the FDA for treatment of type 2 diabetes and is one of the GLP-1 medications prescribed by Calibrate clinicians
Stablegastric Pentadecapeptide BPC 157 Studied for Inflammatory Bowel Disease (PLD-116, PL14736, Pliva) Induces Nitric Oxide Synthesis
No specific interaction between AOD 9604 and alcohol has been identified
Timing considerations: BPC-157 can be administered at any time, though some prefer splitting into morning and evening doses
In 1936, endocrinologist Hans Selye had published a landmark paper in Nature, describing how many different harms toxins, injury, and cold temperature can trigger the same biological stress response
Unlike oral supplements, these treatments deliver nutrients directly into the bloodstream, allowing for up to 90% absorption for more efficient, effective results